anthralin has been researched along with Chronic Illness in 27 studies
Anthralin: An anthracene derivative that disrupts MITOCHONDRIA function and structure and is used for the treatment of DERMATOSES, especially PSORIASIS. It may cause FOLLICULITIS.
anthralin : An anthracene compound derived by the substitution of -OH groups for hydrogen at C-1 and C-8, and with an oxo group at C-9.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A prospective randomized clinical trial was conducted on 50 patients with Alopecia areata who received DPCP alone (group D) or in combination with anthralin (group D/A)." | 9.41 | A randomized trial of diphenylcyclopropenone (DPCP) combined with anthralin versus DPCP alone for treating moderate to severe alopecia areata. ( Abedini, R; Aryanian, Z; Daneshmand, R; Ghandi, N; Hatami, P; Nasimi, M; Vance, TM, 2021) |
| "In a multicenter study 210 patients with moderate to severe chronic plaque-type psoriasis were randomly assigned to treatment with cyclosporine or etretinate." | 9.08 | Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement. ( Färber, L; Mahrle, G; Schulze, HJ; Steigleder, GK; Weidinger, G, 1995) |
| "Fifty patients with psoriasis undergoing a standard Ingram regime were entered into a double-blind comparison of oral indomethacin and placebo." | 9.07 | The effect of oral indomethacin on psoriasis treated with the Ingram regime. ( Goodfield, MJ; Rowell, NR; Sheehan-Dare, RA, 1991) |
| "0125% clobetasol propionate in the treatment of chronic plaque psoriasis was undertaken." | 9.06 | Anthralin-corticosteroid combination therapy in the treatment of chronic plaque psoriasis. ( Clement, MI; du Vivier, A; Hehir, ME; Monk, BE; Pembroke, AC, 1988) |
| "We present a new method for the outpatient use of anthralin paste in the treatment of psoriasis." | 9.05 | Paper-tape occlusion of anthralin paste. A new outpatient therapy for psoriasis. ( Burns, J; Cannon, TC; Engelhard, CS; Pearlman, DL, 1984) |
| "Eighteen patients with chronic plaque psoriasis were investigated in two groups to determine the optimal contact time for the application of 2% anthralin, within the range immediate removal to removal at 20 min." | 7.67 | Short contact anthralin in the treatment of psoriasis: a study of different contact times. ( MacDonald, KJ; Marks, J, 1986) |
| "Anthralin 1% is an effective therapy for AA and should be continued at least 9 months." | 6.84 | Bilateral Half-Head Comparison of 1% Anthralin Ointment in Children with Alopecia Areata. ( Balevi, A; Özdemir, M, 2017) |
| "Anthralin was applied to psoriatic plaques on one side in the following fashion: anthralin 0." | 6.69 | A comparative study of calcipotriol and anthralin for chronic plaque psoriasis in a day care treatment center. ( Dutz, JP; Lui, H, 1998) |
| "A prospective randomized clinical trial was conducted on 50 patients with Alopecia areata who received DPCP alone (group D) or in combination with anthralin (group D/A)." | 5.41 | A randomized trial of diphenylcyclopropenone (DPCP) combined with anthralin versus DPCP alone for treating moderate to severe alopecia areata. ( Abedini, R; Aryanian, Z; Daneshmand, R; Ghandi, N; Hatami, P; Nasimi, M; Vance, TM, 2021) |
| "In a multicenter study 210 patients with moderate to severe chronic plaque-type psoriasis were randomly assigned to treatment with cyclosporine or etretinate." | 5.08 | Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement. ( Färber, L; Mahrle, G; Schulze, HJ; Steigleder, GK; Weidinger, G, 1995) |
| "Fifty patients with psoriasis undergoing a standard Ingram regime were entered into a double-blind comparison of oral indomethacin and placebo." | 5.07 | The effect of oral indomethacin on psoriasis treated with the Ingram regime. ( Goodfield, MJ; Rowell, NR; Sheehan-Dare, RA, 1991) |
| "0125% clobetasol propionate in the treatment of chronic plaque psoriasis was undertaken." | 5.06 | Anthralin-corticosteroid combination therapy in the treatment of chronic plaque psoriasis. ( Clement, MI; du Vivier, A; Hehir, ME; Monk, BE; Pembroke, AC, 1988) |
| "We present a new method for the outpatient use of anthralin paste in the treatment of psoriasis." | 5.05 | Paper-tape occlusion of anthralin paste. A new outpatient therapy for psoriasis. ( Burns, J; Cannon, TC; Engelhard, CS; Pearlman, DL, 1984) |
| "Eighteen patients with chronic plaque psoriasis were investigated in two groups to determine the optimal contact time for the application of 2% anthralin, within the range immediate removal to removal at 20 min." | 3.67 | Short contact anthralin in the treatment of psoriasis: a study of different contact times. ( MacDonald, KJ; Marks, J, 1986) |
| "Anthralin 1% is an effective therapy for AA and should be continued at least 9 months." | 2.84 | Bilateral Half-Head Comparison of 1% Anthralin Ointment in Children with Alopecia Areata. ( Balevi, A; Özdemir, M, 2017) |
| "Anthralin was applied to psoriatic plaques on one side in the following fashion: anthralin 0." | 2.69 | A comparative study of calcipotriol and anthralin for chronic plaque psoriasis in a day care treatment center. ( Dutz, JP; Lui, H, 1998) |
| "Although many other topical treatments for psoriasis (occlusive therapy and vitamin D3 analogues) result in a prominent reduction in the amount of transglutaminase and involucrin positive cell layers, the effect of dithranol on these markers is minimal." | 1.29 | Epidermal differentiation characteristics of the psoriatic plaque during short contact treatment with dithranol cream. ( de Jong, EM; van de Kerkhof, PC; van der Vleuten, CJ, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (48.15) | 18.7374 |
| 1990's | 11 (40.74) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (7.41) | 24.3611 |
| 2020's | 1 (3.70) | 2.80 |
| Authors | Studies |
|---|---|
| Ghandi, N | 1 |
| Daneshmand, R | 1 |
| Hatami, P | 1 |
| Abedini, R | 1 |
| Nasimi, M | 1 |
| Aryanian, Z | 1 |
| Vance, TM | 1 |
| Ibrahim, SA | 1 |
| Esawy, AM | 1 |
| Abdelshafy, AS | 1 |
| Özdemir, M | 1 |
| Balevi, A | 1 |
| Portnoy, B | 1 |
| Beck, MH | 1 |
| Reshad, H | 1 |
| Barth, JH | 1 |
| Darley, CR | 1 |
| Baker, H | 1 |
| Pearlman, DL | 1 |
| Burns, J | 1 |
| Cannon, TC | 1 |
| Engelhard, CS | 1 |
| Ferguson, A | 1 |
| Maden, CJ | 1 |
| Wilson, PD | 1 |
| Ive, FA | 1 |
| Khan, SA | 1 |
| Williamson, DM | 1 |
| Gatecliff, M | 1 |
| Tosh, J | 1 |
| Budden, MG | 1 |
| Marks, J | 3 |
| Rogers, S | 2 |
| Chadkirk, B | 1 |
| Shuster, S | 2 |
| Mahrle, G | 1 |
| Schulze, HJ | 1 |
| Färber, L | 1 |
| Weidinger, G | 1 |
| Steigleder, GK | 1 |
| Boehncke, WH | 1 |
| Sterry, W | 1 |
| Kaufmann, R | 1 |
| van der Vleuten, CJ | 1 |
| de Jong, EM | 1 |
| van de Kerkhof, PC | 2 |
| Dutz, JP | 1 |
| Lui, H | 1 |
| Pietrzak, A | 2 |
| Miturski, R | 1 |
| Krasowska, D | 2 |
| Postawski, K | 1 |
| Lecewicz-Toruń, B | 2 |
| Sander, P | 1 |
| Happe, M | 1 |
| Stücker, M | 1 |
| Hermes, N | 1 |
| Hoffmann, K | 1 |
| Altmeyer, P | 1 |
| Briffa, DV | 1 |
| Warin, A | 1 |
| Greaves, M | 1 |
| Millard, LG | 1 |
| Whitefield, M | 1 |
| Jekler, J | 1 |
| Swanbeck, G | 1 |
| Sheehan-Dare, RA | 1 |
| Goodfield, MJ | 1 |
| Rowell, NR | 1 |
| Rotstein, H | 1 |
| Baker, C | 1 |
| Monk, BE | 1 |
| Hehir, ME | 1 |
| Clement, MI | 1 |
| Pembroke, AC | 1 |
| du Vivier, A | 1 |
| MacDonald, KJ | 1 |
1 review available for anthralin and Chronic Illness
| Article | Year |
|---|---|
The treatment of psoriasis.
Topics: Administration, Oral; Administration, Topical; Anthralin; Anti-Inflammatory Agents; Bed Rest; Chroni | 1990 |
17 trials available for anthralin and Chronic Illness
| Article | Year |
|---|---|
A randomized trial of diphenylcyclopropenone (DPCP) combined with anthralin versus DPCP alone for treating moderate to severe alopecia areata.
Topics: Adolescent; Adult; Age of Onset; Alopecia Areata; Anthralin; Chronic Disease; Cyclopropanes; Drug Th | 2021 |
Bilateral Half-Head Comparison of 1% Anthralin Ointment in Children with Alopecia Areata.
Topics: Administration, Topical; Adolescent; Alopecia Areata; Anthralin; Child; Chronic Disease; Dermatologi | 2017 |
The treatment of active chronic psoriasis: a comparison of the effectiveness of a preparation containing 0.1% dithranol and 17% urea in a cream base and 0.1% dithranol in Lassar's past B.P.C.
Topics: Adolescent; Adult; Aged; Anthracenes; Anthralin; Chronic Disease; Clinical Trials as Topic; Female; | 1981 |
Paper-tape occlusion of anthralin paste. A new outpatient therapy for psoriasis.
Topics: Administration, Topical; Adult; Ambulatory Care; Anthracenes; Anthralin; Bandages; Chronic Disease; | 1984 |
The treatment of chronic psoriasis in general practice: a multicentre trial.
Topics: Anthralin; Betamethasone Valerate; Chronic Disease; Clinical Trials as Topic; Female; Humans; Male; | 1982 |
Dithrocream in psoriasis.
Topics: Adolescent; Adult; Aged; Anthracenes; Anthralin; Chronic Disease; Clinical Trials as Topic; Double-B | 1980 |
The treatment of chronic psoriasis a two-centre comparative study.
Topics: Adolescent; Adult; Aged; Anthracenes; Anthralin; Chronic Disease; Clinical Trials as Topic; Coal Tar | 1981 |
A multicentre general practice study to compare Psoradrate 0.1% and Dithrocream 0.1% in the treatment of chronic psoriasis.
Topics: Adolescent; Adult; Aged; Anthracenes; Anthralin; Chronic Disease; Clinical Trials as Topic; Dermatol | 1982 |
Clearance of chronic plaque psoriasis by anthralin-subjective and objective assessment and comparison with photochemotherapy.
Topics: Anthralin; Chronic Disease; Humans; Photochemotherapy; Psoriasis; PUVA Therapy | 1981 |
Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement.
Topics: Administration, Cutaneous; Adult; Anthralin; Arthritis, Psoriatic; Blood Pressure; Chronic Disease; | 1995 |
A comparative study of calcipotriol and anthralin for chronic plaque psoriasis in a day care treatment center.
Topics: Administration, Topical; Adolescent; Adult; Aged; Ambulatory Care Facilities; Anthralin; Anti-Inflam | 1998 |
Concentration of an epidermal growth factor in blood serum of males during topical treatment of psoriasis.
Topics: Acute Disease; Administration, Cutaneous; Administration, Topical; Anthralin; Anti-Inflammatory Agen | 1999 |
[Tazarotene increases the antipsoriatic effect of dithranol in chronic psoriasis].
Topics: Anthralin; Chronic Disease; Dermatologic Agents; Drug Combinations; Drug Synergism; Female; Gels; Hu | 1999 |
Comparison of photochemotherapy and dithranol in the treatment of chronic plaque psoriasis.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Anthracenes; Anthralin; Chronic Di | 1979 |
One-minute dithranol therapy in psoriasis: a placebo-controlled paired comparative study.
Topics: Adolescent; Adult; Aged; Anthralin; Chronic Disease; Double-Blind Method; Drug Administration Schedu | 1992 |
The effect of oral indomethacin on psoriasis treated with the Ingram regime.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anthralin; Chronic Disease; Coal Tar; Double-Blind Me | 1991 |
Anthralin-corticosteroid combination therapy in the treatment of chronic plaque psoriasis.
Topics: Adolescent; Adult; Aged; Anthralin; Betamethasone; Chronic Disease; Clobetasol; Coal Tar; Combined M | 1988 |
9 other studies available for anthralin and Chronic Illness
| Article | Year |
|---|---|
Treatment of chronic extensive alopecia areata by diphenylcyclopropenone alone versus in combination with anthralin.
Topics: Administration, Topical; Adolescent; Adult; Alopecia Areata; Anthralin; Child; Child, Preschool; Chr | 2019 |
Does UV-A potentiate 'short contact' dithranol therapy?
Topics: Adolescent; Adult; Anthracenes; Anthralin; Chronic Disease; Drug Administration Schedule; Drug Combi | 1984 |
Treatment of psoriasis by topical photodynamic therapy with polychromatic light.
Topics: Administration, Topical; Aminolevulinic Acid; Anthralin; Chronic Disease; Follow-Up Studies; Humans; | 1994 |
Epidermal differentiation characteristics of the psoriatic plaque during short contact treatment with dithranol cream.
Topics: Administration, Cutaneous; Adult; Anthralin; Cell Differentiation; Chronic Disease; Epidermis; Femal | 1996 |
The Woronoff zone surrounding the psoriatic plaque.
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Chronic Disease; Drug Eruptions; Femal | 1998 |
Serum level of sELAM-1 in psoriatic patients correlates with disease activity.
Topics: Acute Disease; Administration, Cutaneous; Administration, Topical; Adult; Anthralin; Anti-Inflammato | 1999 |
Dithranol for psoriasis.
Topics: Anthracenes; Anthralin; Chronic Disease; Cost-Benefit Analysis; Humans; Photochemotherapy; Psoriasis | 1979 |
Dithranol for psoriasis.
Topics: Anthracenes; Anthralin; Chronic Disease; Drug Evaluation; Humans; Ointments; Photochemotherapy; Psor | 1979 |
Short contact anthralin in the treatment of psoriasis: a study of different contact times.
Topics: Adolescent; Adult; Aged; Anthracenes; Anthralin; Child; Chronic Disease; Color; Drug Administration | 1986 |